{"id":823164,"date":"2025-03-07T13:51:52","date_gmt":"2025-03-07T18:51:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/"},"modified":"2025-03-07T13:51:52","modified_gmt":"2025-03-07T18:51:52","slug":"levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/","title":{"rendered":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, March  07, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>BioAge Labs, Inc.<\/strong> (&#8220;BioAge&#8221; or the &#8220;Company&#8221;) (NASDAQ: BIOA) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and\/or traceable to BioAge\u2019s registration statement for the initial public offering held on or about September 26, 2024. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hYksXtWPzq_PW0l51SA4l0pohJZuw0YwV7CF1tdWm3xUwYhvZfNS_Ko2fJ6yPzlIvQXthsIzdN0dPzhGvg3tyeXbvcTINIEMRi8fZ9cmrs91OsPI9rRAPM-Oy6Tp0VVqpLAEDDJCjHKTGwrncvmyuFu2dXAf0c0vL-Hvhqt-F_JVRiV6WYNHjGhLfhbOqsmuFxwI-_zluPVkBsfBX9i2vaj-ry3T2L3ZzvwLRR4b0AxwIc0Ooj9q2WHjpFysl0W0\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/bioage-labs-inc-lawsuit-submission-form?prid=134380&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>BIOA<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w6lk5mAPsXV09mPtLcGK_EqDDjdsU_oR3tKmgpSBmrkmGntHL2TRBZnMEj8m7T3QtjDURbpu-WG54BErfsOu-QnY8NvKaFykd9OUTN74SqU=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>According to the complaint, on December 6, 2024, BioAge announced that it would discontinue the ongoing STRIDES Phase 2 trial for azelaprag, its lead product candidate, citing safety concerns over elevated liver transaminase levels in participants. This came as a surprise because, at the time of its IPO less than three months earlier, BioAge highlighted azelaprag&#8217;s potential in patients undergoing obesity therapy with incretin drugs. Following this news, BioAge\u2019s stock price declined from $20.09 per share on December 6, 2024 to $4.65 per share on December 7, 2024.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in BioAge during the relevant time frame, you have until <strong>March 10, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 17th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w6lk5mAPsXV09mPtLcGK_EqDDjdsU_oR3tKmgpSBmrkQbLfcDzQffF10NenttOgz0BJ53_Iw4sTJxj9i5txO-gjlvcuGsmeKKUrk3XjRmjA=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<br \/><\/a>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TyKUhirFaIbrGA583tyfHSMPQlIgvoJ7K2Pk8ZpDnzu77hpSxm24O7sVcONB9_c6g2UQEGpocU-HfWfzf4CtwA==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MThkMTllN2YtOGZjYS00ZWY5LWJmMGYtZWRlOTM0NGVlYmQ3LTEwMzIyOTM=\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in BioAge Labs, Inc. (&#8220;BioAge&#8221; or the &#8220;Company&#8221;) (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and\/or traceable to BioAge\u2019s registration statement for the initial public offering held on or about September 26, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/bioage-labs-inc-lawsuit-submission-form?prid=134380&amp;wire=3 BIOA investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-823164","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in BioAge Labs, Inc. (&#8220;BioAge&#8221; or the &#8220;Company&#8221;) (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and\/or traceable to BioAge\u2019s registration statement for the initial public offering held on or about September 26, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/bioage-labs-inc-lawsuit-submission-form?prid=134380&amp;wire=3 BIOA investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to &hellip; Continue reading &quot;Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-07T18:51:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders\",\"datePublished\":\"2025-03-07T18:51:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/\"},\"wordCount\":414,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/\",\"name\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=\",\"datePublished\":\"2025-03-07T18:51:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/","og_locale":"en_US","og_type":"article","og_title":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - Market Newsdesk","og_description":"NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in BioAge Labs, Inc. (&#8220;BioAge&#8221; or the &#8220;Company&#8221;) (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and\/or traceable to BioAge\u2019s registration statement for the initial public offering held on or about September 26, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/bioage-labs-inc-lawsuit-submission-form?prid=134380&amp;wire=3 BIOA investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to &hellip; Continue reading \"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-07T18:51:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders","datePublished":"2025-03-07T18:51:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/"},"wordCount":414,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/","name":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=","datePublished":"2025-03-07T18:51:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MDU3MSM2Nzk1MDMxIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-bioage-labs-inc-bioa-shareholders-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/823164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=823164"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/823164\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=823164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=823164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=823164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}